Improving CPR training can save more lives
A new statement "Resuscitation education science: educational strategies to improve outcomes from cardiac arrest" published by the American Heart Association (AHA) in the journal Circulation has highlights the shortcomings in education for resuscitation and says that more people will survive cardiac arrest if these are addressed. The statement also has suggestions for improvement in training on eight key elements:... read more
Add pulses to your diet to keep blood sugar levels controlled
A study published April 11, 2018 in the Journal of Nutrition analyzing four dishes - white rice only, half white rice and half large green lentils, half white rice and half small green lentils, and half white rice and half split red lentils - found that replacing half a serving of rice with lentils caused blood glucose to drop by up to 20% and replacing potatoes with lentils led to a 35 % decline in blood sugar levels in healthy adults.... read more
Viruses may have a role in Alzheimer’s disease
A study funded by NIH and published June 21, 2018 in the journal Neuron has suggested that viruses, particularly herpesviruses, may have a role in Alzheimer’s disease biology. Although the study does not show cause and effect, it shows that viral DNA sequences and activation of biological networks, the interrelated systems of DNA, RNA, proteins and metabolites may interact with molecular, genetic and clinical aspects of the disease..... read more
Reducing proteinuria reduces CKD progression in children
Analysis of data from the Effect of Strict Blood Pressure Control and ACE inhibition on the Progression of CRF in Pediatric Patients (ESCAPE) trial has shown that anti-hypertensive drugs reduced proteinuria, which reduced the risk of disease progression in children with chronic kidney disease (CKD). These findings are published June 21, 2018 online in the Journal of the American Society of Nephrology.... read more
First continuous glucose monitoring system with a fully implantable glucose sensor
The US Food and Drug Administration (FDA) has approved the Eversense Continuous Glucose Monitoring (CGM) system for use in people 18 years of age and older with diabetes. This is the first FDA-approved CGM system to include a fully implantable sensor to detect glucose and compatible mobile app, which can be worn for up to 90 days.
.... read more
Eptinezumab effectively prevents migraine, says study
Results of the phase III PROMOSE-2 (Prevention of Migraine via Intravenous Eptinezumab Safety and Efficacy 2) trial presented at the American Academy of Neurology (AAN) 2018 Annual Meeting in Los Angeles show that eptinezumab 100-mg or 300-mg dose significantly reduced monthly migraine days (MMDs) over weeks 1 to 12 compared with placebo.
.... read more